Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Breakthrough Oxford study moves newborn screening for SMA towards nationwide rollout

A major national study led by the University of Oxford to evaluate newborn screening for spinal muscular atrophy (SMA) has been funded by the National Institute for Health and Care Research (NIHR), marking a significant milestone towards the potential introduction of SMA screening across the UK.

University of Oxford secures two International Cardiovascular Research Partnership Awards

Two research groups at the University of Oxford have been awarded funding through the prestigious International Cardiovascular Research Partnership Awards, to support high-quality international research collaborations that have the potential to accelerate progress towards improved understanding, prevention, diagnosis and treatment of cardiovascular disease.

OpenBind releases first open dataset and AI model for drug discovery

The OpenBind consortium’s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery.

Oxford researchers join global network unravelling the complexity of Parkinson’s disease

Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) from Nuffield Department of Clinical Neurosciences (NDCN) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Professor Adrian Hill selected as a finalist for the European Inventor Award 2026

The European Patent Office has announced that Professor Adrian Hill, Lakshmi Mittal Professor of Vaccinology and Director of the Jenner Institute at Oxford University, is one of three finalists in the ‘Research’ category of the European Inventor Award for his development of a vaccine against Malaria.

New AI model predicts how cells choose their fate

Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.

Heart scan and blood test improve risk prediction for inherited heart condition, major study finds

A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) – a heart condition that is the most frequent cause of sudden cardiac death in younger individuals.

New compound developed to target hypoxia by reducing tumour oxygen consumption

Researchers from the Department of Oncology in collaboration with the Department of Chemistry have developed a promising new compound designed to reduce tumour hypoxia, a major cause of radiotherapy resistance.

The Department of Physiology, Anatomy and Genetics (DPAG) has announced their new Head of Department

Professor Richard Wade-Martins has formally accepted the offer to become DPAG's new Head of Department.

MSc in Global Healthcare Leadership students launch global health venture platform, Synergya, a new platform for scaling health and sustainability ventures

Two students from the University of Oxford’s MSc in Global Healthcare Leadership programme, jointly delivered by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and Saïd Business School, have co-founded a new social enterprise called ‘Synergya’, designed to help health and sustainability ventures scale through structured collaboration.

Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes

On World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes.

Better cognition tied to higher relapse risk after depression remission

Oxford and Birmingham study with more than 3,700 UK participants challenges idea that cognitive decline would be associated with relapse risk

New study improves early detection of life threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.

New research programme to strengthen the evaluation of implants in the NHS

A major new NIHR funded programme grant aims to make medical implants safer and better value for money in the NHS. The project will develop a robust framework to assess the long-term risks, benefits and costs of implants.

World’s largest study of women’s health marks 30 years of pioneering research

Thirty years after its launch, the Million Women Study continues to shape evidence on HRT, cancer, ageing, and women’s health.

“Switching off” the ovaries reduces the risk of breast cancer recurrence by one-fifth in younger women

Study shows suppressing ovarian function can significantly lower breast cancer recurrence risk in younger women already taking tamoxifen.

Inviting nature into a secure ward for young people

A team from the University of Oxford and Oxford Health NHS Foundation Trust created a therapeutic horticulture garden in a psychiatric intensive care unit for young people, as part of a new study looking at how green spaces can benefit patients and staff.

Phase 2 Endometriosis study highlights a novel molecular imaging agent as a promising diagnostic and monitoring tool

A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, ‘99mTc-maraciclatide’, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.

New rabies vaccine could provide protection for adults and children with a single dose

A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.

New model of care could prevent more than 10,000 miscarriages a year in the UK, Tommy’s report suggests

A new study by Tommy’s researchers, led by Professor Arri Coomarasamy, from the Nuffield Department of Women’s & Reproductive Health, suggests that offering follow-up care from the first miscarriage could help prevent around 10,000 pregnancy losses each year in the UK.

Load More